A trial of buspirone for anxiety in Parkinson's disease: Safety and tolerability-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A trial of buspirone for anxiety in Parkinson's disease: Safety and tolerability

Published:2020-12 Issue: Volume:81 Page:69-74
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Schneider Ruth B.,Auinger Peggy,Tarolli Christopher G.,Iourinets Julia,Gil-Díaz María Cristina,Richard Irene H.

Funder

The Michael J. Fox Foundation for Parkinson's Research

NINDS

New York State Department of Health

Publisher

Elsevier BV

Subject

Neurology (clinical),Geriatrics and Gerontology,Neurology

Reference29 articles.

1. Prevalence of anxiety in Parkinson's disease: as systematic review and meta-analysis;Broen;Mov. Disord.,2016

2. Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms;Duncan;Mov. Disord.,2014

3. Pharmacologic treatment of anxiety disorders in Parkinson disease;Pontone;Am. J. Geriatr. Psychiatr.,2013

4. Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a double-blind, placebo-controlled study;Maricle;Neurology,1995

5. Serotonin transporter binding and anxiety symptoms in Parkinson's disease;Joling;J. Neurol. Neurosurg. Psychiatry,2018

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Side effects and cognitive benefits of buspirone: A systematic review and meta-analysis;Heliyon;2024-04

2. 5-HT_1A agonists for levodopa-induced dyskinesia in Parkinson's disease;Neurodegenerative Disease Management;2023-04

3. Anxiety in Parkinson’s Patients: What’s Timing Got to Do with It?;Journal of Geriatric Psychiatry and Neurology;2023-03-09

4. Neurobiology of depression in Parkinson’s disease: Insights into epidemiology, molecular mechanisms and treatment strategies;Ageing Research Reviews;2023-03

5. Treatment for cognitive and neuropsychiatric non-motor symptoms in Parkinson’s disease: current evidence and future perspectives;Expert Review of Neurotherapeutics;2023-01-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3